Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
The risk of bacterial contamination increases significantly as the benzyl alcohol degrades
TB-500 has been through Phase I and Phase II clinical trials of intravenous thymosin beta-4 with no serious adverse events reported in the published cohorts
The trials reported minimal injection site issues, with no concerning patterns of local inflammation, infection, or tissue damage
NAD+ (25mg
Yet, the short duration of the study did not permit a conclusion on whether the lowering of homocysteine through B-vitamin supplementation could have long-term benefits on bone strength and fracture risk (119)
Our Derby clinic offers one-on-one consultations where we design a plan just for you
